STXS Company Profile and Key Details

STXS has shown mixed momentum, gaining 3.13% over the past week and -11.71% over the past quarter, though year-to-date performance is up 14.78%. Short-term trend indicators are bullishly aligned (SMA20 4.79%, SMA50 -5.81%, SMA200 -11.36%). The stock’s 14-day RSI is 50.02 (neutral), while the ATR of 0.12 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -38.44% below its high and over 43.51% above its low. Average 10-day trading volume of 520.87 thousand shares is below the 3-month average of 809.58 thousand, indicating normal recent market interest.

Stereotaxis, Inc. generated EPS of -$0.28 over the past year. Five-year average earnings growth is -25.52%. Wall Street analysts project EPS growth of 25.48% annually over the next five years. The latest quarter delivered EPS of -$0.05. The next quarter is forecast at -$0.06. Next year's EPS is expected at $12.73. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $4.00 to $3.50. The high target offers 183.69% upside. The low target suggests 148.23% downside. The mean target is $3.88. This offers 175.18% upside. Stereotaxis, Inc. earnings surprise history is a mixed track record. The quarter that ended August 11, 2026, missed forecasts by 0.0%. The prior quarter beat by 50.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in May 12, 2025.

Stereotaxis, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.09. This means the shares are trading below this model’s fair value.

Stereotaxis, Inc. has 100.20 million shares outstanding. The public float is 65.54 million shares, elevated short interest at 5.32% of float. This equals 4.48 million shares. The short ratio is 3.58 days. Institutional investors hold 51.64% of the float. Insiders own 15.2%. Mills William C. III holds 239.71 thousand shares, Benfer David has 155.00 thousand shares and Isaac Paul J has 97.30 thousand shares.

Stereotaxis, Inc. (AMEX:STXS) closed at $1.41 USD, losing -$0.01 (-0.70%) from the previous close of $1.42. The stock is currently mid-range between its 52-week high and low $1.24 and $3.59. With a market capitalization of about $138.09 million, Stereotaxis, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.40). Key stats such as the average daily volume over the past year has been around 825.25 thousand shares, volume is running light vs its 52-week average. Headquartered in St. Louis, MO, Stereotaxis, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO David L. Fischel, the company employs approximately 131 people and listed since August 12, 2004. Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease.

Stereotaxis, Inc. trades at a P/E ratio of -5.71, slightly below the S&P 500 average, with a price-to-sales ratio of 4.59 and a price-to-book ratio of 8.07 trading at moderately above to book value. The P/FCF stands at -8.91, also below market averages.

Stereotaxis, Inc. (AMEX:STXS) shares are up 14.78% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Stereotaxis, Inc. trading at a premium to the broader market with a P/E of -5.71. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $6.15, suggesting 336.17% upside. Our AI forecast model points to short-term strength (4.26% over two weeks), a medium-term fall (-59.57% over three months), and a longer-term gain (39.01% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Stereotaxis, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.26%, with price expected at $1.47 by September 08, 2026, within a range of $1.41 to $1.54 3-Month Outlook: Projected fall of -59.57%, reaching $0.57 by November 23, 2026, with a range of $0.52 to $0.62. 1-Year Outlook: Projected gain of 39.01%, with price at $1.96 by August 25, 2027, within a range of $0.00 to $0.35.